RUNX1 Loss of Function Drives Resistance to Lenalidomide in Del(5Q) Myelodysplastic Syndrome Patients. (April 2017) - Martinez-Høyer, S.; Mo, A.; Docking, R.; Li, J.; Chan, S.; Umlandt, P.; Fuller, M.; Jädersten, M.; Hellström-Lindberg, E.; Platzbecker, U.; Parker, J.; Karsan, A.